BioCentury
ARTICLE | Financial News

Actinium raises $5.1M ahead of reverse-merger

December 27, 2012 1:49 AM UTC

Actinium Pharmaceuticals Inc. (Newark, N.J.) raised $5.1 million through the sale of about 9.3 million units in the first close of a bridge financing. Each unit comprises a share, a 120-day warrant to purchase a share at $0.55 and a five-year warrant to purchase 0.5 shares at $0.83. Laidlaw was placement agent. Actinium said it plans to raise up to $15 million in the bridge financing and go public via a reverse merger by year end (see BioCentury, Aug. 27). ...